AAOI Applied Optoelectronics | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Leopold Subscribe to MarketBeat All Access for the recommendation accuracy rating | $37.82 +16.8% | $17.00 ➝ $39.00 | Outperform ➝ Outperform | |
ABX Barrick Gold | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$22.22 +1.4% | C$21.00 | Buy | |
AC Air Canada | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$21.96 +1.1% | C$25.50 ➝ C$28.00 | Buy | |
ACN Accenture | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $366.37 -1.6% | $355.00 ➝ $385.00 | Hold ➝ Hold | |
ACN Accenture | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $366.37 -1.6% | $390.00 ➝ $425.00 | Market Perform ➝ Market Perform | |
ACN Accenture | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $366.37 -1.6% | $450.00 ➝ $455.00 | Buy ➝ Buy | |
This Crypto Is Set to Explode in December (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
ADEN ADENTRA | Target Set by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.64 +2.7% | C$60.00 | Strong-Buy | |
AFRM Affirm | Upgraded by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Scharf Subscribe to MarketBeat All Access for the recommendation accuracy rating | $65.64 +4.2% | $78.00 ➝ $78.00 | Market Perform ➝ Outperform | |
AFRM Affirm | Upgraded by | Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Scharf Subscribe to MarketBeat All Access for the recommendation accuracy rating | $65.64 +4.2% | | Hold ➝ Strong-Buy | |
AIRJ Montana Technologies | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $9.50 +0.7% | $12.00 | Buy | |
ALAB Astera Labs | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $132.17 +5.5% | $94.00 ➝ $142.00 | Overweight ➝ Overweight | |
ALMS Alumis | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $8.82 +2.2% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
AMD Advanced Micro Devices | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $119.21 +0.3% | $169.00 ➝ $158.00 | Equal Weight ➝ Equal Weight | |
AMZN Amazon.com | Target Raised by | Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.92 +0.7% | $245.00 ➝ $290.00 | Buy ➝ Buy | |
ANF Abercrombie & Fitch | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $154.56 +0.9% | $201.00 ➝ $204.00 | Overweight ➝ Overweight | |
APLD Applied Digital | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Knoblauch Subscribe to MarketBeat All Access for the recommendation accuracy rating | $8.01 -0.5% | $15.00 | Overweight | |
APLT Applied Therapeutics | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Abrahams Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.88 -13.7% | $4.00 ➝ $1.50 | Sector Perform ➝ Sector Perform | |
APO Apollo Global Management | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $171.03 +0.8% | $168.00 ➝ $196.00 | Outperform ➝ Outperform | |
APR.UN Automotive Properties Real Est Invt TR | Target Set by | National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$11.01 +2.5% | C$13.00 | Outperform | |
AQST Aquestive Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.65 +0.3% | $10.00 ➝ $10.00 | Buy ➝ Buy | |
ARES Ares Management | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Voigt Subscribe to MarketBeat All Access for the recommendation accuracy rating | $176.04 +2.9% | $166.00 ➝ $202.00 | Market Perform ➝ Outperform | |
AROW Arrow Financial | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | F. Schiraldi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $29.00 +1.2% | $32.00 | Neutral | |
ARWR Arrowhead Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.45 -0.3% | $80.00 ➝ $80.00 | Buy ➝ Buy | |
AS Amer Sports | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | I. Boruchow Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.18 +2.5% | $20.00 ➝ $25.00 | Equal Weight ➝ Equal Weight | |
ATD Alimentation Couche-Tard | Target Set by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$80.79 +1.6% | C$91.00 | Outperform | |
ATO Atmos Energy | Upgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.69 +1.2% | $150.00 | Hold ➝ Buy | |
ATRA Atara Biotherapeutics | Initiated by | Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.40 +14.8% | $25.00 | Buy | |
ATRA Atara Biotherapeutics | Upgraded by | RODMAN&RENSHAW Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Butler Subscribe to MarketBeat All Access for the recommendation accuracy rating | $11.40 +14.8% | | Strong-Buy | |
AVGO Broadcom | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $220.79 +1.1% | $233.00 ➝ $265.00 | Overweight ➝ Overweight | |
BAM Brookfield Asset Management | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.42 +0.4% | $49.00 ➝ $57.00 | Underperform ➝ Underperform | |
BB BlackBerry | Upgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.69 +23.8% | $3.25 ➝ $4.00 | Hold ➝ Buy | |
BB BlackBerry | Upgraded by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Chan Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.69 +23.8% | $3.25 ➝ $4.00 | Hold ➝ Buy | |
BB BlackBerry | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.69 +23.8% | $3.00 ➝ $3.50 | Neutral ➝ Neutral | |
BB BlackBerry | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.69 +23.8% | $2.80 ➝ $3.00 | Hold ➝ Hold | |
BB BlackBerry | Upgraded by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Chan Subscribe to MarketBeat All Access for the recommendation accuracy rating | C$5.27 +23.1% | | Hold ➝ Strong-Buy | |
BEN Franklin Resources | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.49 +2.6% | $18.00 ➝ $19.00 | Underweight ➝ Underweight | |
BIIB Biogen | Downgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Seigerman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $146.47 -0.6% | $230.00 ➝ $164.00 | Outperform ➝ Market Perform | |
BKD Brookdale Senior Living | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.13 +2.6% | $8.00 ➝ $8.00 | Outperform ➝ Outperform | |
BKD Brookdale Senior Living | Reiterated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.13 +2.6% | $8.00 ➝ $8.00 | Outperform ➝ Outperform | |
BKU BankUnited | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.10 +1.8% | $45.00 ➝ $44.00 | Equal Weight ➝ Equal Weight | |
This Crypto Is Set to Explode in December (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
BLK BlackRock | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,028.69 +1.2% | $1,245.00 ➝ $1,261.00 | Overweight ➝ Overweight | |
BLND Blend Labs | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.40 -0.7% | $5.75 ➝ $5.75 | Buy ➝ Buy | |
BPOP Popular | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.66 +1.2% | $110.00 ➝ $115.00 | Overweight ➝ Overweight | |
BRKL Brookline Bancorp | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Moss Subscribe to MarketBeat All Access for the recommendation accuracy rating | $11.94 +3.6% | $16.00 | Market Perform ➝ Strong-Buy | |
BSIG BrightSphere Investment Group | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.01 -3.6% | $26.00 ➝ $25.00 | Underweight ➝ Underweight | |
BX Blackstone | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $170.84 +1.1% | $169.00 ➝ $175.00 | Market Perform ➝ Market Perform | |
CABA Cabaletta Bio | Downgraded by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Clark-Gartner Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.38 +3.0% | $15.00 ➝ $6.00 | Outperform ➝ Inline | |
CAC Camden National | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Moss Subscribe to MarketBeat All Access for the recommendation accuracy rating | $43.42 +2.7% | $50.00 | Market Perform ➝ Outperform | |
CAG Conagra Brands | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.11 +1.1% | $31.00 ➝ $29.00 | Neutral ➝ Neutral | |
CAG Conagra Brands | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.11 +1.1% | $29.00 ➝ $29.00 | Sector Perform ➝ Sector Perform | |
CAS Cascades | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$11.47 +2.0% | C$12.00 ➝ C$13.00 | Sector Perform | |
CBOE Cboe Global Markets | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $191.61 -1.1% | $217.00 ➝ $220.00 | Market Perform ➝ Market Perform | |
CECO CECO Environmental | Target Raised by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.49 0.0% | $35.00 ➝ $38.00 | Outperform ➝ Outperform | |
CFP Canfor | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$14.79
| C$21.00 ➝ C$19.00 | Outperform | |
CFX Canfor Pulp Products | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$0.76
| C$1.25 ➝ C$1.00 | Sector Perform | |
CHMG Chemung Financial | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | F. Schiraldi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $50.05 +0.7% | $57.00 | Neutral | |
CHP.UN Choice Properties Real Est Invstmnt Trst | Target Set by | National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$13.35 +1.4% | C$15.50 | Sector Perform | |
CLS Celestica | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.45 +2.6% | $77.00 ➝ $110.00 | Buy | |
CME CME Group | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $238.53 +0.7% | $237.00 ➝ $260.00 | Market Perform ➝ Market Perform | |
CMPR Cimpress | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.21 +0.7% | $119.00 ➝ $119.00 | Outperform ➝ Outperform | |
COIN Coinbase Global | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $278.71 +1.7% | $165.00 ➝ $275.00 | Market Perform ➝ Market Perform | |
CRC California Resources | Initiated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.56 -0.8% | $63.00 | Neutral | |
CRSP CRISPR Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.72 +0.8% | $86.00 ➝ $86.00 | Market Outperform ➝ Market Outperform | |
CRT.UN CT Real Estate Investment Trust | Target Set by | National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$14.55 +3.2% | C$16.25 | Sector Perform | |
CSL Carlisle Companies | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $378.27 +0.1% | $505.00 ➝ $495.00 | Outperform ➝ Outperform | |
CTAS Cintas | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $186.94 +2.3% | $225.00 ➝ $215.00 | Buy ➝ Buy | |
CTAS Cintas | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $186.94 +2.3% | $240.00 ➝ $218.00 | Buy ➝ Buy | |
CTAS Cintas | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $186.94 +2.3% | $209.00 ➝ $200.00 | Neutral ➝ Neutral | |
CTAS Cintas | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating | $186.94 +2.3% | $191.00 ➝ $184.00 | Underweight ➝ Underweight | |
CTAS Cintas | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating | $186.94 +2.3% | $215.00 ➝ $215.00 | Sector Perform ➝ Sector Perform | |
CTAS Cintas | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $186.94 +2.3% | $236.00 ➝ $211.00 | Buy ➝ Buy | |
CVE Cenovus Energy | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$20.71 +0.2% | C$33.00 ➝ C$32.00 | Buy | |
CYTK Cytokinetics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.87 +4.6% | $120.00 ➝ $120.00 | Buy ➝ Buy | |
DASH DoorDash | Upgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Ruggeri Subscribe to MarketBeat All Access for the recommendation accuracy rating | $171.00 +2.0% | | Hold ➝ Buy | |
DH Definitive Healthcare | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.18 +1.0% | $5.00 | Equal Weight | |
DLTR Dollar Tree | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $72.94 +5.6% | $75.00 ➝ $75.00 | Market Perform ➝ Market Perform | |
DNTH Dianthus Therapeutics | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Werber Subscribe to MarketBeat All Access for the recommendation accuracy rating | $23.80 +3.3% | | Buy | |
DOCS Doximity | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $57.83 +4.8% | $55.00 | Equal Weight | |
DRI Darden Restaurants | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $195.00 ➝ $211.00 | Buy ➝ Buy | |
DRI Darden Restaurants | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $165.00 ➝ $175.00 | Market Perform ➝ Market Perform | |
DRI Darden Restaurants | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $195.00 ➝ $210.00 | Buy ➝ Buy | |
DRI Darden Restaurants | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $190.00 ➝ $205.00 | Buy ➝ Buy | |
DRI Darden Restaurants | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $195.00 ➝ $200.00 | Buy ➝ Buy | |
DRI Darden Restaurants | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $182.00 ➝ $200.00 | Outperform ➝ Outperform | |
DRI Darden Restaurants | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $180.00 ➝ $194.00 | Neutral ➝ Neutral | |
DRI Darden Restaurants | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $200.00 ➝ $220.00 | Outperform ➝ Outperform | |
DRI Darden Restaurants | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating | $187.59 +2.3% | $164.00 ➝ $175.00 | Equal Weight ➝ Equal Weight | |
DRI Darden Restaurants | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $192.00 ➝ $206.00 | Overweight ➝ Overweight | |
DRI Darden Restaurants | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59 +2.3% | $194.00 ➝ $200.00 | Overweight ➝ Overweight | |
EAT Brinker International | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $134.26 +2.2% | $70.00 ➝ $115.00 | Underweight ➝ Equal Weight | |
Your bank is lying to you. (Ad) You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts. View the best savings account rates here |
ENPH Enphase Energy | Upgraded by | OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.45 +8.6% | | Negative ➝ Mixed | |
ET Energy Transfer | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.86 +3.2% | $18.00 ➝ $22.00 | Overweight ➝ Overweight | |
EVGO EVgo | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.36 +1.9% | $8.00 ➝ $7.00 | Overweight ➝ Overweight | |
EXEL Exelixis | Downgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Darout Subscribe to MarketBeat All Access for the recommendation accuracy rating | $33.29 -1.2% | $36.00 ➝ $40.00 | Outperform ➝ Market Perform | |
FCEL FuelCell Energy | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.42 +11.7% | $15.00 ➝ $8.40 | Hold ➝ Hold | |
FCEL FuelCell Energy | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.42 +11.7% | $12.00 ➝ $12.00 | Hold ➝ Hold | |
FCEL FuelCell Energy | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.42 +11.7% | $2.00 ➝ $12.00 | Hold | |
FDS FactSet Research Systems | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $483.52 -1.3% | $503.00 ➝ $503.00 | Sector Perform ➝ Sector Perform | |
FDS FactSet Research Systems | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $483.52 -1.3% | $469.00 ➝ $493.00 | Hold ➝ Hold | |
FDX FedEx | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $321.00 ➝ $368.00 | Buy ➝ Buy | |
FDX FedEx | Upgraded by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Paterson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $275.73 -0.1% | $288.00 ➝ $365.00 | Hold ➝ Buy | |
FDX FedEx | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $328.00 ➝ $337.00 | Hold ➝ Buy | |
FDX FedEx | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $275.73 -0.1% | $305.00 ➝ $320.00 | Equal Weight ➝ Equal Weight | |
FDX FedEx | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $366.00 ➝ $370.00 | Overweight ➝ Overweight | |
FDX FedEx | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $305.00 ➝ $320.00 | Outperform ➝ Outperform | |
FDX FedEx | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $325.00 ➝ $348.00 | Buy ➝ Buy | |
FDX FedEx | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $300.00 ➝ $330.00 | Market Perform ➝ Market Perform | |
FDX FedEx | Target Lowered by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $350.00 ➝ $345.00 | Overweight ➝ Overweight | |
FDX FedEx | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.73 -0.1% | $311.00 ➝ $350.00 | Buy ➝ Buy | |
FENC Fennec Pharmaceuticals | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.99 +2.6% | $13.00 | Outperform | |
FHN First Horizon | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.94 +3.5% | $23.00 ➝ $25.00 | Overweight ➝ Overweight | |
FICO Fair Isaac | Initiated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2,090.98 +2.3% | $2,150.00 | Neutral | |
FISI Financial Institutions | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | F. Schiraldi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $27.12 +1.8% | $33.00 | Overweight | |
FMC FMC | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.15 +4.8% | $75.00 ➝ $66.00 | Buy ➝ Buy | |
FNV Franco-Nevada | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.21 +0.9% | $200.00 ➝ $155.00 | Buy ➝ Buy | |
FREY FREYR Battery | Upgraded by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.16 +19.3% | $4.00 | Neutral ➝ Buy | |
FRT Federal Realty Investment Trust | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $111.92 +2.2% | $122.00 ➝ $125.00 | Neutral ➝ Overweight | |
GIS General Mills | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.61 -0.6% | $74.00 ➝ $68.00 | Equal Weight ➝ Equal Weight | |
GOLD Barrick Gold | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.46 +1.5% | $23.00 ➝ $17.00 | Neutral | |
GT Goodyear Tire & Rubber | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.62 +0.3% | $10.00 | Hold | |
GTLS Chart Industries | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $184.83 +2.2% | $138.00 ➝ $201.00 | Neutral ➝ Neutral | |
HAL Halliburton | Downgraded by | Griffin Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Simpson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $25.97 +0.8% | | Buy ➝ Neutral | |
HLI Houlihan Lokey | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $173.97 +0.7% | $171.00 ➝ $172.00 | Market Perform ➝ Market Perform | |
HLNE Hamilton Lane | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $150.68 -0.5% | $215.00 ➝ $167.00 | Market Perform ➝ Market Perform | |
HOOD Robinhood Markets | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.33 +3.8% | $24.00 ➝ $38.00 | Market Perform ➝ Market Perform | |
HOOK Hookipa Pharma | Downgraded by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Abrahams Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.02 -5.6% | $48.00 ➝ $2.00 | Outperform ➝ Sector Perform | |
HR Healthcare Realty Trust | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.88 +1.1% | $19.00 | Overweight ➝ Neutral | |
HUMA Humacyte | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.64 +34.1% | $12.00 ➝ $15.00 | Buy ➝ Buy | |
HUMA Humacyte | Reiterated by | D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.64 +34.1% | $25.00 ➝ $25.00 | Buy ➝ Buy | |
IBKR Interactive Brokers Group | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Voigt Subscribe to MarketBeat All Access for the recommendation accuracy rating | $175.92 +1.2% | $152.00 ➝ $190.00 | Market Perform ➝ Market Perform | |
IBRX ImmunityBio | Reiterated by | D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62 -1.9% | $30.00 ➝ $30.00 | Buy ➝ Buy | |
IFP Interfor | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$16.83 +0.8% | C$27.00 ➝ C$26.00 | Outperform | |
IFRX InflaRx | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.24 +5.2% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
IIPR Innovative Industrial Properties | Downgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.66 -22.7% | $118.00 ➝ $70.00 | Neutral ➝ Underweight | |
IIPR Innovative Industrial Properties | Downgraded by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Ross Subscribe to MarketBeat All Access for the recommendation accuracy rating | $73.66 -22.7% | $125.00 ➝ $78.00 | Buy ➝ Neutral | |
INSG Inseego | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.81 -0.6% | $17.00 ➝ $12.00 | Hold ➝ Hold | |
INVZ Innoviz Technologies | Upgraded by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.15 +9.5% | $3.25 ➝ $4.00 | Neutral ➝ Buy | |
IONQ IonQ | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.42 +17.6% | $22.00 ➝ $45.00 | Buy ➝ Buy | |
IONS Ionis Pharmaceuticals | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.63 +0.1% | | Outperform | |
IONS Ionis Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.63 +0.1% | $60.00 ➝ $60.00 | Buy ➝ Buy | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
IQV IQVIA | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $197.27 +3.0% | $250.00 | Overweight | |
IREN Iris Energy | Initiated by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating | $11.81 +3.5% | $33.00 | Buy | |
IVZ Invesco | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.33 +3.3% | $18.00 ➝ $19.00 | Equal Weight ➝ Equal Weight | |
IVZ Invesco | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.33 +3.3% | $19.00 ➝ $18.00 | Market Perform ➝ Market Perform | |
JBL Jabil | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $145.00 +3.2% | $157.00 ➝ $179.00 | Overweight ➝ Overweight | |
JCI Johnson Controls International | Upgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Eade Subscribe to MarketBeat All Access for the recommendation accuracy rating | $80.64 +2.5% | $88.00 | Hold ➝ Buy | |
JHG Janus Henderson Group | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.55 +2.0% | $46.00 ➝ $48.00 | Equal Weight ➝ Equal Weight | |
JRVR James River Group | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61 +1.3% | $11.00 ➝ $8.00 | Market Outperform ➝ Market Outperform | |
KIM Kimco Realty | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.42 +1.8% | $26.00 | Overweight ➝ Neutral | |
KKR KKR & Co. Inc. | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.58 +2.8% | $163.00 ➝ $170.00 | Outperform ➝ Outperform | |
KMX CarMax | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.27 +0.0% | $72.00 ➝ $88.00 | Hold ➝ Hold | |
KMX CarMax | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.27 +0.0% | $70.00 ➝ $72.00 | Underweight ➝ Underweight | |
KMX CarMax | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.27 +0.0% | $72.00 ➝ $80.00 | Neutral ➝ Neutral | |
KMX CarMax | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.27 +0.0% | $90.00 ➝ $98.00 | Buy ➝ Buy | |
KR Kroger | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.85 +1.5% | $70.00 ➝ $75.00 | Buy ➝ Buy | |
KRC Kilroy Realty | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.50 +4.1% | $45.00 ➝ $49.00 | Neutral ➝ Overweight | |
LAZ Lazard | Downgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Hall Subscribe to MarketBeat All Access for the recommendation accuracy rating | $52.04 +3.1% | $65.00 ➝ $57.00 | Outperform ➝ Market Perform | |
LCNB LCNB | Initiated by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Nosal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.24 -3.0% | $16.25 | Market Perform | |
LEN Lennar | Downgraded by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Reichardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | $138.08 -0.2% | | Buy ➝ Neutral | |
LEN Lennar | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Bouley Subscribe to MarketBeat All Access for the recommendation accuracy rating | $138.08 -0.2% | $181.00 ➝ $135.00 | Equal Weight ➝ Equal Weight | |
LEN Lennar | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.08 -0.2% | $225.00 ➝ $205.00 | Buy ➝ Buy | |
LEN Lennar | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.08 -0.2% | $160.00 ➝ $130.00 | Underperform ➝ Underperform | |
LEN Lennar | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.08 -0.2% | $210.00 ➝ $170.00 | Outperform ➝ Outperform | |
LGO Largo | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.70 +1.8% | $4.20 ➝ $4.20 | Buy ➝ Buy | |
LINE Lineage | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.57 +2.9% | $78.00 ➝ $75.00 | Overweight ➝ Neutral | |
LPLA LPL Financial | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $327.93 +0.1% | $325.00 ➝ $390.00 | Outperform ➝ Outperform | |
LQDA Liquidia | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $11.10 +4.8% | $20.00 | Overweight | |
LUMN Lumen Technologies | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.92 -2.3% | $4.00 ➝ $4.25 | Sector Perform ➝ Sector Perform | |
LVTX LAVA Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.03 +4.2% | $6.00 ➝ $2.00 | Buy ➝ Buy | |
LW Lamb Weston | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.09 -0.7% | $80.00 ➝ $68.00 | Hold ➝ Hold | |
LW Lamb Weston | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $62.09 -0.7% | $90.00 ➝ $68.00 | Buy ➝ Neutral | |
LXP LXP Industrial Trust | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.32 +1.2% | | Market Perform ➝ Market Perform | |
MC Moelis & Company | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Hall Subscribe to MarketBeat All Access for the recommendation accuracy rating | $73.81 +2.9% | $71.00 ➝ $86.00 | Market Perform ➝ Outperform | |
MCO Moody's | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Christiansen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $466.35 +0.9% | $565.00 | Buy | |
MIDD Middleby | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $134.72 +1.5% | $155.00 ➝ $155.00 | Buy ➝ Buy | |
MKTX MarketAxess | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $230.15 +0.7% | $276.00 ➝ $255.00 | Market Perform ➝ Market Perform | |
MNKD MannKind | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.85 +8.7% | $9.00 | Overweight | |
MNMD Mind Medicine (MindMed) | Initiated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Li Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.16 +2.1% | $20.00 | Buy | |
MPAA Motorcar Parts of America | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Soderberg Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.91 +1.3% | $14.00 | Overweight | |
MRK Merck & Co., Inc. | Downgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Seigerman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $98.05 -1.5% | $136.00 ➝ $105.00 | Outperform ➝ Market Perform | |
MRVL Marvell Technology | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $111.90 +2.6% | $102.00 ➝ $120.00 | Equal Weight ➝ Equal Weight | |
MU Micron Technology | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.12 +3.5% | $145.00 ➝ $110.00 | Overweight ➝ Overweight | |
NBIX Neurocrine Biosciences | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.42 +0.3% | | Hold ➝ Hold | |
NDAQ Nasdaq | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.70 +0.4% | $86.00 ➝ $91.00 | Outperform ➝ Outperform | |
NKE NIKE | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 -0.2% | $79.00 ➝ $75.00 | Hold ➝ Hold | |
NKE NIKE | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.94 -0.2% | $97.00 ➝ $90.00 | Buy ➝ Buy | |
NKE NIKE | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.94 -0.2% | $80.00 ➝ $73.00 | Neutral ➝ Neutral | |
NKE NIKE | Downgraded by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Fernandez Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.94 -0.2% | $93.00 ➝ $80.00 | Outperform ➝ Market Perform | |
NKE NIKE | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 -0.2% | $80.00 ➝ $74.00 | Equal Weight ➝ Equal Weight | |
NKE NIKE | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 -0.2% | $95.00 ➝ $90.00 | Buy ➝ Buy | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
NKE NIKE | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.94 -0.2% | $84.00 ➝ $84.00 | Buy ➝ Buy | |
NKE NIKE | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Yih Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.94 -0.2% | $79.00 ➝ $70.00 | Equal Weight ➝ Equal Weight | |
NOW ServiceNow | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,091.25 +1.5% | $1,000.00 ➝ $1,200.00 | Buy ➝ Buy | |
NRIM Northrim BanCorp | Initiated by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Rabatin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $76.48 -0.8% | $96.50 | Outperform | |
NUS Nu Skin Enterprises | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Xue Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.60 -3.9% | $11.00 ➝ $7.00 | Neutral ➝ Neutral | |
ONB Old National Bancorp | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.50 +2.1% | $26.00 ➝ $27.00 | Overweight ➝ Overweight | |
OPRX OptimizeRx | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.91 +3.4% | $5.50 | Equal Weight | |
ORCL Oracle | Downgraded by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. White Subscribe to MarketBeat All Access for the recommendation accuracy rating | $169.66 +0.5% | $130.00 | Neutral ➝ Sell | |
ORKA Oruka Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $20.31 -2.2% | $45.00 ➝ $45.00 | Buy ➝ Buy | |
OWL Blue Owl Capital | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.49 +1.7% | $22.00 ➝ $26.00 | Market Perform ➝ Market Perform | |
PAYS Paysign | Initiated by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.99 +2.0% | $6.00 | Buy | |
PAYX Paychex | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.54 +1.3% | $148.00 ➝ $148.00 | Sector Perform ➝ Sector Perform | |
PB Prosperity Bancshares | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.95 +1.1% | $84.00 ➝ $88.00 | Equal Weight ➝ Equal Weight | |
PBF PBF Energy | Downgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Gabelman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $25.15 -1.2% | $27.00 ➝ $20.00 | Hold ➝ Sell | |
PCVX Vaxcyte | Initiated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Shibutani Subscribe to MarketBeat All Access for the recommendation accuracy rating | $86.53 +0.4% | $135.00 | Buy | |
PFLT PennantPark Floating Rate Capital | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Dodd Subscribe to MarketBeat All Access for the recommendation accuracy rating | $10.68 -0.3% | | Market Perform | |
PGY Pagaya Technologies | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.95 +2.8% | $33.00 ➝ $11.00 | Neutral ➝ Neutral | |
PJT PJT Partners | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.41 +1.7% | $151.00 ➝ $159.00 | Market Perform ➝ Market Perform | |
PRTA Prothena | Initiated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Li Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.22 -4.9% | $40.00 | Buy | |
PRTA Prothena | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.22 -4.9% | $84.00 ➝ $48.00 | Buy ➝ Buy | |
PSNL Personalis | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75 +9.3% | $7.25 ➝ $7.25 | Buy ➝ Buy | |
PSNL Personalis | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75 +9.3% | $9.00 ➝ $11.00 | Buy ➝ Buy | |
PYXS Pyxis Oncology | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.69 +9.7% | $10.00 ➝ $8.00 | Outperform ➝ Outperform | |
PYXS Pyxis Oncology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.69 +9.7% | $7.00 ➝ $5.00 | Buy ➝ Buy | |
QBTS D-Wave Quantum | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.44 +1.1% | $2.50 ➝ $9.00 | Buy ➝ Buy | |
QBTS D-Wave Quantum | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.44 +1.1% | $3.00 ➝ $8.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.22 +1.7% | $75.00 ➝ $88.00 | Overweight ➝ Overweight | |
RDDT Reddit | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Morris Subscribe to MarketBeat All Access for the recommendation accuracy rating | $170.71 +4.3% | $210.00 | Buy | |
RDDT Reddit | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $170.71 +4.3% | $120.00 ➝ $200.00 | Buy ➝ Buy | |
RGTI Rigetti Computing | Initiated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Shannon Subscribe to MarketBeat All Access for the recommendation accuracy rating | $9.37 +25.4% | $12.00 | Buy | |
RJF Raymond James | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.05 +2.8% | $143.00 ➝ $170.00 | Market Perform ➝ Market Perform | |
RNA Avidity Biosciences | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Ghosh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $31.82 +2.5% | $72.00 | Buy | |
RXST RxSight | Downgraded by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.66 -11.9% | $65.00 ➝ $40.00 | Buy ➝ Hold | |
RYTM Rhythm Pharmaceuticals | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.12 +1.2% | $76.00 | Outperform | |
RZLV Rezolve AI | Reiterated by | D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.96 -2.6% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
SCHW Charles Schwab | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Voigt Subscribe to MarketBeat All Access for the recommendation accuracy rating | $74.31 +0.9% | $81.00 ➝ $93.00 | Outperform ➝ Outperform | |
SEIC SEI Investments | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.75 +1.6% | $76.00 ➝ $86.00 | Market Perform ➝ Market Perform | |
SFTBY SoftBank Group | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.19 -2.8% | | Buy ➝ Hold | |
SLB Schlumberger | Downgraded by | Griffin Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Simpson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $36.83 -0.2% | | Buy ➝ Neutral | |
SMCI Super Micro Computer | Upgraded by | Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating | N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $31.59 +1.1% | | Strong-Buy | |
SPGI S&P Global | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Christiansen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $491.81 +1.1% | $600.00 | Buy | |
SPRO Spero Therapeutics | Downgraded by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.96 -4.3% | $5.00 ➝ $5.00 | Outperform ➝ In-Line | |
SR Spire | Upgraded by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Moreen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $66.69 +1.7% | $65.00 ➝ $76.00 | Neutral ➝ Outperform | |
STEP STEP Energy Services | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$4.18 -14.9% | C$6.25 ➝ C$6.00 | Outperform | |
STOK Stoke Therapeutics | Initiated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Li Subscribe to MarketBeat All Access for the recommendation accuracy rating | $11.68 +3.4% | $24.00 | Buy | |
STT State Street | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.20 +2.9% | $95.00 | Underweight ➝ Neutral | |
STZ Constellation Brands | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Pascarelli Subscribe to MarketBeat All Access for the recommendation accuracy rating | $227.63 +0.3% | $280.00 ➝ $280.00 | Buy ➝ Buy | |
SU Suncor Energy | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.50 -0.3% | $66.00 ➝ $66.00 | Outperform ➝ Outperform | |
SU Suncor Energy | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$49.60 -0.4% | C$62.00 ➝ C$54.00 | Hold | |
SVRA Savara | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.23
| $8.00 | Overweight | |
TEAM Atlassian | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $257.26 +2.4% | $255.00 ➝ $285.00 | Buy ➝ Buy | |
TMP Tompkins Financial | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | F. Schiraldi Subscribe to MarketBeat All Access for the recommendation accuracy rating | $69.38 +2.2% | $70.00 | Neutral | |
TPG TPG | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.82 +1.3% | $62.00 ➝ $70.00 | Market Perform ➝ Market Perform | |
TROW T. Rowe Price Group | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.12 +2.8% | $114.00 ➝ $116.00 | Market Perform ➝ Market Perform | |
TROW T. Rowe Price Group | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.12 +2.8% | $129.00 ➝ $132.00 | Equal Weight ➝ Equal Weight | |
TTC Toro | Target Lowered by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $81.48 +0.5% | $100.00 ➝ $95.00 | Outperform ➝ Outperform | |
USNA USANA Health Sciences | Upgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Xue Subscribe to MarketBeat All Access for the recommendation accuracy rating | $33.38 -3.8% | | Hold | |
VCTR Victory Capital | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.46 +4.6% | $64.00 ➝ $66.00 | Equal Weight ➝ Equal Weight | |
VEEV Veeva Systems | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $224.15 +2.0% | $280.00 | Overweight | |
VERU Veru | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.65 +3.3% | $3.00 ➝ $3.00 | Buy ➝ Buy | |
VET Vermilion Energy | Target Lowered by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | C$12.73 -0.2% | C$18.00 ➝ C$17.00 | Buy | |
VITL Vital Farms | Initiated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Lauriers Subscribe to MarketBeat All Access for the recommendation accuracy rating | $39.69 +2.5% | $50.00 | Buy | |
VRCA Verrica Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Belanger Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.69 +2.6% | | Hold ➝ Hold | |
VRTS Virtus Investment Partners | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $221.00 +1.4% | $224.00 ➝ $228.00 | Underweight ➝ Underweight | |
VRTX Vertex Pharmaceuticals | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $397.27 +0.2% | $566.00 ➝ $520.00 | Outperform ➝ Outperform | |
VRTX Vertex Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $397.27 +0.2% | | Hold ➝ Hold | |
VRTX Vertex Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $397.27 +0.2% | $600.00 ➝ $535.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Wang Subscribe to MarketBeat All Access for the recommendation accuracy rating | $397.27 +0.2% | $509.00 ➝ $418.00 | Equal Weight ➝ Equal Weight | |
VTEX VTEX | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.68 -2.7% | $12.50 ➝ $11.00 | Buy ➝ Buy | |
VTR Ventas | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.76 +1.8% | $65.00 ➝ $66.00 | Neutral ➝ Neutral | |
VVV Valvoline | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.55 +0.8% | $42.00 | Hold | |
VZ Verizon Communications | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.93 -0.1% | $44.00 ➝ $45.00 | Neutral ➝ Neutral | |
WFRD Weatherford International | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.10 -2.1% | $110.00 ➝ $95.00 | Buy ➝ Buy | |
WOOF Petco Health and Wellness | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.96 +0.8% | $6.00 ➝ $6.00 | Outperform ➝ Outperform | |
WTW Willis Towers Watson Public | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $317.57 +2.1% | $352.00 ➝ $382.00 | Hold ➝ Buy | |
X United States Steel | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Jancic Subscribe to MarketBeat All Access for the recommendation accuracy rating | $30.14 -5.0% | $43.00 ➝ $40.00 | Outperform ➝ Outperform | |
XMTR Xometry | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Devitt Subscribe to MarketBeat All Access for the recommendation accuracy rating | $41.67 +13.9% | $48.00 | Outperform | |